The Rise of Incisionless Surgery: A New Era for Men's Health with Tom Tamberrino, Chief Commercial Officer of Profound Medical
What if prostate cancer could be treated without a single incision, and patients could be home having dinner with their families the very same day?
In this episode, Tom Tamberrino, Chief Commercial Officer of Profound Medical, discusses how the company's MRI-guided TULSA-PRO technology is changing prostate treatment through incisionless, minimally invasive procedures. He explains how focused ultrasound, AI-assisted treatment planning, and real-time MRI guidance enable physicians to treat both prostate cancer and benign prostatic hyperplasia while allowing patients to return home the same day…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.